ES2191701T3 - Nuevos macrolidos citotoxicos, su aislamiento de una esponja marina y su uso como agentes antitumorales. - Google Patents

Nuevos macrolidos citotoxicos, su aislamiento de una esponja marina y su uso como agentes antitumorales.

Info

Publication number
ES2191701T3
ES2191701T3 ES95909565T ES95909565T ES2191701T3 ES 2191701 T3 ES2191701 T3 ES 2191701T3 ES 95909565 T ES95909565 T ES 95909565T ES 95909565 T ES95909565 T ES 95909565T ES 2191701 T3 ES2191701 T3 ES 2191701T3
Authority
ES
Spain
Prior art keywords
macrolids
isolation
antitumor agents
marine sponge
new cytotoxic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95909565T
Other languages
English (en)
Spanish (es)
Inventor
Paul A Horton
Frank Koehn
Ross E Longley
Oliver J Mcconnell
Shirley A Pomponi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Harbor Branch Oceanographic Institute Foundation Inc
Original Assignee
Harbor Branch Oceanographic Institution Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harbor Branch Oceanographic Institution Inc filed Critical Harbor Branch Oceanographic Institution Inc
Application granted granted Critical
Publication of ES2191701T3 publication Critical patent/ES2191701T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30—Oxygen atoms, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/181—Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
ES95909565T 1994-02-18 1995-02-17 Nuevos macrolidos citotoxicos, su aislamiento de una esponja marina y su uso como agentes antitumorales. Expired - Lifetime ES2191701T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/198,747 US5478861A (en) 1994-02-18 1994-02-18 Cytotoxic macrolides and methods of use

Publications (1)

Publication Number Publication Date
ES2191701T3 true ES2191701T3 (es) 2003-09-16

Family

ID=22734648

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95909565T Expired - Lifetime ES2191701T3 (es) 1994-02-18 1995-02-17 Nuevos macrolidos citotoxicos, su aislamiento de una esponja marina y su uso como agentes antitumorales.

Country Status (8)

Country Link
US (1) US5478861A (fr)
EP (1) EP0745087B1 (fr)
JP (1) JP3569285B2 (fr)
AT (1) ATE232208T1 (fr)
CA (1) CA2182878C (fr)
DE (1) DE69529562T2 (fr)
ES (1) ES2191701T3 (fr)
WO (1) WO1995022550A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5684036A (en) * 1994-02-18 1997-11-04 Harbor Branch Oceanographic Institution, Inc. Cytotoxic macrolides and methods of use
US7115756B2 (en) * 2003-06-23 2006-10-03 Harbor Branch Oceanographic Institution, Inc. Biologically active lasonolide compounds

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3697547A (en) * 1970-12-18 1972-10-10 Abbott Lab Erythronolide b derivatives
US4164584A (en) * 1977-10-25 1979-08-14 Research Corporation Anti-leukemic trichothecene epoxides
US4548814A (en) * 1980-12-18 1985-10-22 The Board Of Trustees Of The University Of Illinois Composition of matter and process
US4560774A (en) * 1982-11-17 1985-12-24 Arizona State University Macrocyclic lactones
US4743695A (en) * 1984-02-08 1988-05-10 The Board Of Regents For The University Of Oklahoma Tedanolide
US4996229A (en) * 1985-06-06 1991-02-26 University Of Hawaii Scytophycins
DE3669515D1 (de) * 1985-09-13 1990-04-19 Biotechnolog Forschung Gmbh Makrozyklische antibiotika.
US4729996A (en) * 1986-05-29 1988-03-08 Harbor Branch Oceanographic Institution, Inc. Antitumor compositions and their methods of use
US4859782A (en) * 1986-06-26 1989-08-22 Harbor Branch Oceanographic Institution, Inc. Misakinolide compositions and their derivatives
US4833257A (en) * 1986-07-28 1989-05-23 Arizona Board Of Regents Compositions of matter and methods of using same
US4737510A (en) * 1986-09-30 1988-04-12 The Board Of Trustees Of The University Of Illinois Bioactive metabolites from the caribbean sponge agelas coniferin
DE3700331A1 (de) * 1986-12-24 1988-07-07 Hoechst Ag Verfahren zur herstellung der desmalonylverbindung von makrolid-lactonen
US4808590A (en) * 1987-07-17 1989-02-28 Harbor Branch Oceanographic Institution, Inc. Antiviral, antitumor and antifungal compositions and their methods of use
US4939168A (en) * 1989-08-11 1990-07-03 Harbor Branch Oceanographics Institution, Inc. Discodermolide compounds, compositions containing same and methods of preparation and use
US5196447A (en) * 1991-08-08 1993-03-23 Arizona Board Of Regents, A Body Corporate Of The State Of Arizona, Acting On Behalf Of Arizona State University Neristatin 1

Also Published As

Publication number Publication date
JPH09509180A (ja) 1997-09-16
ATE232208T1 (de) 2003-02-15
US5478861A (en) 1995-12-26
DE69529562T2 (de) 2003-08-21
JP3569285B2 (ja) 2004-09-22
WO1995022550A1 (fr) 1995-08-24
EP0745087B1 (fr) 2003-02-05
DE69529562D1 (de) 2003-03-13
CA2182878C (fr) 2007-05-08
EP0745087A1 (fr) 1996-12-04
CA2182878A1 (fr) 1995-08-24

Similar Documents

Publication Publication Date Title
ES2176212T3 (es) Eteres de fosfonooximetilicos o metiltiometilicos de derivados de taxano como agentes antitumorales.
AR006390A1 (es) Derivados de lactama
DE69325130D1 (de) N-sulfonyl-2-oxoindol-derivate mit einer affinität für die vasopressin und/oder ocytocin rezeptoren
AU2002239344A1 (en) Pyrazolopyridines
ES2150918T3 (es) 1h-imidazo(4,5-c)quinolin-4-aminas 1-sustituidas; compuestos intermedios y composiciones farmaceuticas.
ATE296826T1 (de) Pyrazolo(1,5)pyridinderivate
ES2171022T3 (es) Esteres de etilenglicol de derivados de monohidrobenzoporfirinas como agentes fotoactivos.
ECSP109932A (es) Compuestos de biciclolactama sustituida
CO4700455A1 (es) Derivados tetraciclicos y proceso para su preparacion
TR200102836T2 (tr) Bitki zararlılarının kontrol edilmesi için bileşimler.
ES2243579T3 (es) Derivados de pirazolopirideno.
ES2185660T3 (es) Nuevo uso de dexmedetomidina.
ES2124884T3 (es) Nuevos derivados de prednisolona.
MXPA02012752A (es) Agentes herbicidas.
IT1271325B (it) Composti diastereomericamente puri derivati da 3-oxo e 3-tioxo-4-azaandrostani e loro uso come antiandrogeni
AR029942A1 (es) Compuestos derivados de 1,3-dihidro-2h-indol-2-ona, su utilizacion, procedimiento para su preparacion y composiciones farmaceuticas que los comprenden, medicamentos constituidos por dichos compuestos y compuestos intermediarios
AR027539A1 (es) Nuevos derivados de 1,3-dihidro-2h-indol-2-ona, un procedimiento para su preparacion y las composiciones farmaceuticas que los contienen
UY26920A1 (es) 7 - oxo piridopirimidinas
CO4940435A1 (es) Sal de hemisulfato del (1s,4r)-cis-4-[2-amino-6- (ciclopropilamino)-9h-purin-9-il]-2-ciclopenten-1-metanol o un solvato del mismo
AR022740A1 (es) Analogos opticamente puros de la camptotecina, composiciones farmaceuticas que los contienen y uso de los mismos como agentes antitumorales
AR004551A1 (es) Compuestos fungicidas (b)
UY26250A1 (es) Sulfonamidas sustituidas con naftilo
AR006675A1 (es) 4-benzoilisotiazoles herbicidas, procedimiento para obtenerlas, las composiciones herbicidas que las contienen y el procedimiento de aplicacionde dichos compuestos.
AR013749A1 (es) Tratamiento de retinopatia diabetica
ATE232208T1 (de) Cytotoxische makrolide, deren isolierung aus meeresschwämmen und deren verwendung als antitumormittel